logo

For the Inventor, By the Inventor

Munich, Germany

Daiichi Sankyo Europe Gmbh


USPTO Granted Patents = 14



Trademarks = 2

Forward Citations = 32

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Thore Hettmann (6 out of 11 patents)

silverMedal Reimar Abraham (5 out of 6 patents)

bronzeMedal Daniel Freeman (4 out of 49 patents)

4.  Sabine Blum (4 out of 5 patents)

5.  Mike Rothe (3 out of 44 patents)

6.  Martin Treder (3 out of 6 patents)

7.  Deric L Wheeler (2 out of 2 patents)

8.  Suguru Ueno (2 out of 2 patents)

9.  Robert Radinsky (2 out of 11 patents)

10.  Keisuke Fukuchi (2 out of 17 patents)

11.  Eric Borges (2 out of 19 patents)

12.  Larry L Green (2 out of 71 patents)

13.  Susanne Hartmann (2 out of 5 patents)

14.  Xiaoping Jin (2 out of 3 patents)

15.  Robert Allen Beckman (2 out of 3 patents)


14 patents:

1. 12497666 - Nucleic acid biomarker and use thereof (2025-12-16),
2. 12139549 - Material and methods for treating or preventing HER-3 associated diseases (2024-11-12),
3. 11873344 - Protein biomarker and uses thereof (2024-01-16),
4. 11351259 - HER3 inhibitor for modulating radiosensitivity (2022-06-07),
5. 11298359 - Anti-HER3 antibody-drug conjugate (2022-04-12),
6. 11267900 - Antibodies directed to HER-3 and uses thereof (2022-03-08),
7. 10995143 - Combination of human anti-FGFR4 antibody and Sorafenib (2021-05-04),
8. 10765738 - Combination of anti-FGFR4-antibody and bile acid sequestrant (2020-09-08),
9. 10383878 - Anti-HER3 antibody-drug conjugate (2019-08-20),
10. 10365283 - Activated HER3 as a marker for predicting therapeutic efficacy (2019-07-30),
11. 10358498 - Human anti-FGFR4 antibody (2019-07-23),
12. 10357566 - HER3 inhibitor for modulating radiosensitivity (2019-07-23),
13. 10100124 - Antibodies directed to HER-3 and uses thereof (2018-10-16),
14. 9803025 - Material and methods for treating or preventing HER-3 associated diseases (2017-10-31),
Daiichi Sankyo Europe GmbH is a pharmaceutical company specializing in research, development, and marketing of innovative pharmaceutical products. With a focus on cardiovascular diseases, oncology, and neurology, the company aims to improve patient outcomes and address unmet medical needs. Daiichi Sankyo Europe GmbH is committed to delivering innovative healthcare solutions to patients, healthcare professionals, and society.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

14 Patents

#142 in W-8000 Munich

#2,902 in Germany

#40,959 in the World

...
Munich, Germany

Daiichi Sankyo Europe Gmbh

Forward Citations = 32

25 inventors:

goldMedal Thore Hettmann (6 out of 11 patents)

silverMedal Reimar Abraham (5 out of 6 patents)

bronzeMedal Daniel Freeman (4 out of 49 patents)

4.  Sabine Blum (4 out of 5 patents)

5.  Mike Rothe (3 out of 44 patents)

Please report any incorrect information to support@idiyas.com
Loading…